The tumor suppressor gene PDCD4 has been validated as a miR-21 target in prostate cancer [62], glioblastoma [63], retinoblastoma [64], lung cancer [8], thyroid carcinoma [65], colorectal cancer [66], and renal cell carcinoma [67]. The gene discussed is PDCD4; the disease is prostate cancer.